Increasing Use of the Vaccine Against Zoster Through Recommendation and Administration by Ophthalmologists at a City Hospital

Jung, Jesse J.; Elkin, Zachary; Li, Xiaochun; Goldberg, Judith D.; Edell, Aimée R. P.; Cohen, Michael; Chen, Kevin C.; Perskin, Michael H.; Park, Lisa; Cohen, Elisabeth J.

doi:10.1016/j.ajo.2012.11.022

Cited by 12 publications

(4 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Çalışmamızda ise aile hekimlerinin %16.6'sı erkek hastalarına da HPV aşısını önerdi-ğini belirtmiştir. Jung ve arkadaşları (33)'nın, 60 yaş üzerindeki hastalara yaptıkları anket çalışmasında, katılımcıların %46.9'u aile hekimlerine danışmadan zona aşısı olmayacaklarını belirtmiştir (33). Bu sonuç, aile hekimlerinin zona aşısı hakkındaki tutumlarının önemini göstermektedir.…”

Section: İrdelemeunclassified

Awareness and Attitude of Family Physicians About Human Papilloma Virus and Herpes Zoster Vaccines

Revanli¹,

Yuceer²,

Şenol³

et al. 2016

Klimik Dergisi

View full text Add to dashboard Cite

Objective: In this study, it is aimed to examine knowledge and attitudes about HPV and herpes zoster vaccines among family physicians. Methods: The study was conducted at 5th Annual International Family Practice Congress (19-23 Decembe, 2014, Antalya, Turkey) using face-to-face survey forms handed out to 263 family physicians. Statistical data has been analyzed using STATA 9.0 program. Results: Majority of the participants (89.3%) had knowledge about HPV vaccine and 156 (59.5%) of them had been recommending the HPV vaccine to their patients. The main reason of not prescribing (50.3%) was expensiveness. It is observed that recommending the vaccine is correlated with having knowledge about the vaccine (p<0.001). The physicians who have knowledge about HPV vaccine (p=0.006) and are older than 40 years of age (p=0.016) are more likely to prescribe HPV vaccine. The number of participants with some knowledge about herpes zoster vaccine was 157 (59.7%) and 161 (65.7%) of the participants were in favor of recommending the vaccine. According to multivariate analysis, recommending herpes zoster vaccine correlates with having knowledge about the vaccine (p=0.043), being woman (p=0.03), being older than 40 years (p=0.007) and having had shingles or having a relative who have had shingles (p=0.006). 3)'ü HPV aşısı hakkında bilgi sahibidir ve bunların 156 (%59.5)'sı HPV aşısını hastalarına önermektedir. HPV aşısının reçete edilmemesinin en büyük nedeni (%50.3) pahalı olmasıdır. Aşı hakkında bilgi sahibi olunmasının hastalara HPV aşısının önerilmesiyle ilişkili olduğu bulunmuştur (p<0.001). HPV aşısı hakkında bilgi sahibi olanların (p=0.006) ve 40 yaşın üzerindeki hekimlerin (p=0.016) daha sık HPV aşısı reçete ettiği saptanmıştır. Anket formu uygulanan katılımcıların 157 (%59.7)'si zona aşısı hakkında bilgi sahibidir ve 161 (%65.7)'i hastalarına zona aşısı önermeye olumlu bakmaktadır. Çok değişkenli analize göre aşı hakkında bilgi sahibi olma (p=0.043), kadın olma (p=0.03), 40 yaşın üzerinde olma (p=0.007), kendisinin veya bir yakınının zona geçirmiş olması (p=0.006) hekimlerin hastalarına zona aşısı önermesiyle ilişkili bulunmuştur. Sonuçlar: HPV ve zona aşılarını önermede ve HPV aşısını reçete etmede temel belirleyici aile hekimlerinin bu konulardaki bilgi düzeyleridir. HPV ve zona aşılarının indikasyonlu hastalara önerilmesi için, aile hekimlerinin bu konuda bilgilendirilmesi gerekmektedir. Klimik Dergisi 2016; 29(1): 15-20. Anahtar Sözcükler: HPV, HPV aşısı, zona, zona aşısı, aile hekimleri.

show abstract

Section: İrdelemeunclassified

Awareness and Attitude of Family Physicians About Human Papilloma Virus and Herpes Zoster Vaccines

Revanli¹,

Yuceer²,

Şenol³

et al. 2016

Klimik Dergisi

View full text Add to dashboard Cite

show abstract

“…Barriers to use of the ZV in the USA include high cost, complex and partial reimbursement, frozen storage requirement and lack of a strong recommendation by primary-care doctors 40 41. Despite interventions to overcome these barriers, including education, availability at pharmacies and electronic medical record reminders, primary-care doctors do not consider this vaccine as important as influenza and pneumonia vaccines 42 43.…”

Section: The Zoster Vaccinementioning

confidence: 99%

“…Despite interventions to overcome these barriers, including education, availability at pharmacies and electronic medical record reminders, primary-care doctors do not consider this vaccine as important as influenza and pneumonia vaccines 42 43. Ophthalmologists can also recommend this vaccine to their patients 41. Implementation of evidence-based medical practices requires changes first in knowledge, then attitudes and finally practice 44.…”

Section: The Zoster Vaccinementioning

confidence: 99%

Persistent dilemmas in zoster eye disease

Cohen

Kessler

2015

Br J Ophthalmol

View full text Add to dashboard Cite

Herpes zoster ophthalmicus (HZO) is a common, vision and potentially life-threatening disease caused by the reactivation of the varicella-zoster virus (VZV) in the distribution of the first division of cranial nerve V. Although the rate of herpes zoster increases with age, over half of the people with zoster in general, including HZO, are under age 60. In addition, over 90% of people with zoster are immunocompetent, even though the disease is more common and severe in immunocompromised patients. The incidence of zoster is increasing worldwide for unknown reasons. The epidemiology has not yet been impacted by the zoster vaccine (ZV). The lack of a strong recommendation by physicians for this vaccine is a major barrier to its use. An unresolved dilemma regards the optimum timing for this vaccine. In the USA, the current recommendation by the Centers for Disease Control and Prevention (CDC) is for eligible people age 60 and older, despite its greater efficacy in reducing the incidence of disease and Food and Drug Administration (FDA) approval for age 50-59. Although there is a consensus regarding use of acute high-dose oral antiviral treatment to reduce ocular complications, there is limited evidence for prolonged treatment. The rationale for a proposed randomised controlled trial (RCT) of suppressive antiviral treatment to reduce chronic eye disease and postherpetic neuralgia (PHN) includes evidence that zoster is followed by chronic active VZV infection and similarities between HZO and herpes simplex virus (HSV) eye infection, where this treatment is effective and is the standard of care.

show abstract

“…Despite showing over 51% and 70% efficacy in adults over age 50 and 60, respectively, the live attenuated vaccine had low coverage rates: studies estimate between 12% and 32% of vaccine-eligible adults have received the HZ vaccine [8][9][10]. Many possible contributing factors to the low vaccination rate have been proposed, including high cost, a lack of consensus on vaccine recommendation, waning efficacy, supply issues, and general lack of awareness of the vaccine and its benefits [11][12][13][14][15][16][17][18][19][20]. Influences on general awareness and interest in the HZ vaccine are poorly understood, and if known they could be utilized in designing more effective public health efforts to increase HZ immunizations.…”

Section: Introductionmentioning

confidence: 99%

Monitoring Interest in Herpes Zoster Vaccination: Analysis of Google Search Data (Preprint)

Berlinberg¹,

Deiner²,

Porco³

et al. 2018

Preprint

View full text Add to dashboard Cite

BACKGROUND A new recombinant subunit vaccine for herpes zoster (HZ or shingles) was approved by the United States Food and Drug Administration on October 20, 2017 and is expected to replace the previous live attenuated vaccine. There have been low coverage rates with the live attenuated vaccine (Zostavax), ranging from 12-32% of eligible patients receiving the HZ vaccine. OBJECTIVE This study aimed to provide insight into trends and potential reasons for interest in HZ vaccination. METHODS Internet search data were queried from the Google Health application programming interface from 2004-2017. Seasonality of normalized search volume was analyzed using wavelets and Fisher’s g test. RESULTS The search terms “shingles vaccine,” “zoster vaccine,” and “zostavax” all exhibited significant periodicity in the fall months (P<.001), with sharp increases after recommendations for vaccination by public health-related organizations. Although the terms “shingles blisters,” “shingles itch,” “shingles rash,” “skin rash,” and “shingles medicine” exhibited statistically significant periodicities with a seasonal peak in the summer (P<.001), the terms “shingles contagious,” “shingles pain,” “shingles treatment,” and “shingles symptoms” did not reveal an annual trend. CONCLUSIONS There may be increased interest in HZ vaccination during the fall and after public health organization recommendations are broadcast. This finding points to the possibility that increased awareness of the vaccine through public health announcements could be evaluated as a potential intervention for increasing vaccine coverage.

show abstract

Increasing Use of the Vaccine Against Zoster Through Recommendation and Administration by Ophthalmologists at a City Hospital

Cited by 12 publications

References 28 publications

Awareness and Attitude of Family Physicians About Human Papilloma Virus and Herpes Zoster Vaccines

Awareness and Attitude of Family Physicians About Human Papilloma Virus and Herpes Zoster Vaccines

Persistent dilemmas in zoster eye disease

Monitoring Interest in Herpes Zoster Vaccination: Analysis of Google Search Data (Preprint)

Contact Info

Product

Resources

About